Mills K - Search Results

1

The identification of new biomarkers for identifying and monitoring kidney disease and their translation into a rapid mass spectrometry-based test: evidence of presymptomatic kidney disease in pediatric Fabry and type-I diabetic patients.

Manwaring V, Heywood WE, Clayton R, Lachmann RH, Keutzer J, Hindmarsh P, Winchester B, Heales S, Mills K. Manwaring V, et al. Among authors: mills k. J Proteome Res. 2013 May 3;12(5):2013-21. doi: 10.1021/pr301200e. Epub 2013 Apr 2. J Proteome Res. 2013. PMID: 23464927

2

Application of magnetic chromatography to the isolation of lysosomes from fibroblasts of patients with lysosomal storage disorders.

Diettrich O, Mills K, Johnson AW, Hasilik A, Winchester BG. Diettrich O, et al. Among authors: mills k. FEBS Lett. 1998 Dec 28;441(3):369-72. doi: 10.1016/s0014-5793(98)01578-6. FEBS Lett. 1998. PMID: 9891973 Free article.

3

Congenital disorders of glycosylation type I leads to altered processing of N-linked glycans, as well as underglycosylation.

Mills P, Mills K, Clayton P, Johnson A, Whitehouse D, Winchester B. Mills P, et al. Among authors: mills k. Biochem J. 2001 Oct 15;359(Pt 2):249-54. doi: 10.1042/0264-6021:3590249. Biochem J. 2001. PMID: 11583570 Free PMC article.

4

Identification of alpha(1)-antitrypsin variants in plasma with the use of proteomic technology.

Mills K, Mills PB, Clayton PT, Johnson AW, Whitehouse DB, Winchester BG. Mills K, et al. Among authors: mills pb. Clin Chem. 2001 Nov;47(11):2012-22. Clin Chem. 2001. PMID: 11673370

5

Analysis by matrix assisted laser desorption/ionisation-time of flight mass spectrometry of the post-translational modifications of alpha 1-antitrypsin isoforms separated by two-dimensional polyacrylamide gel electrophoresis.

Mills PB, Mills K, Johnson AW, Clayton PT, Winchester BG. Mills PB, et al. Among authors: mills k. Proteomics. 2001 Jun;1(6):778-86. doi: 10.1002/1615-9861(200106)1:6<778::AID-PROT778>3.0.CO;2-H. Proteomics. 2001. PMID: 11677785

6

Synthesis of novel internal standards for the quantitative determination of plasma ceramide trihexoside in Fabry disease by tandem mass spectrometry.

Mills K, Johnson A, Winchester B. Mills K, et al. FEBS Lett. 2002 Mar 27;515(1-3):171-6. doi: 10.1016/s0014-5793(02)02491-2. FEBS Lett. 2002. PMID: 11943216 Free article.

7

The underglycosylation of plasma alpha 1-antitrypsin in congenital disorders of glycosylation type I is not random.

Mills K, Mills PB, Clayton PT, Mian N, Johnson AW, Winchester BG. Mills K, et al. Among authors: mills pb. Glycobiology. 2003 Feb;13(2):73-85. doi: 10.1093/glycob/cwg026. Epub 2002 Dec 17. Glycobiology. 2003. PMID: 12626422

8

Mass spectrometric analysis of glycans in elucidating the pathogenesis of CDG type IIx.

Mills PB, Mills K, Mian N, Winchester BG, Clayton PT. Mills PB, et al. Among authors: mills k. J Inherit Metab Dis. 2003;26(2-3):119-34. doi: 10.1023/a:1024476915278. J Inherit Metab Dis. 2003. PMID: 12889655 Review.

9

Monitoring the clinical and biochemical response to enzyme replacement therapy in three children with Fabry disease.

Mills K, Vellodi A, Morris P, Cooper D, Morris M, Young E, Winchester B. Mills K, et al. Eur J Pediatr. 2004 Oct;163(10):595-603. doi: 10.1007/s00431-004-1484-z. Eur J Pediatr. 2004. PMID: 15243806

10

Measurement of urinary CDH and CTH by tandem mass spectrometry in patients hemizygous and heterozygous for Fabry disease.

Mills K, Morris P, Lee P, Vellodi A, Waldek S, Young E, Winchester B. Mills K, et al. J Inherit Metab Dis. 2005;28(1):35-48. doi: 10.1007/s10545-005-5263-4. J Inherit Metab Dis. 2005. PMID: 15702404

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,105 results

Search Page

Filters